Skip to search formSkip to main contentSkip to account menu

Perineural Invasion Assessment

Known as: PNLINV, Perineural Invasion 
An evaluation of the presence or degree of perineural invasion present in a sample.
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SEND Microscopic Findings Test Name TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen‐deprivation therapy in high‐risk prostate cancer following radical prostatectomy
Background: Perineural invasion (PNI) is a distinct pathologic entity and a recognized source of tumor spread. However, the role… 
2014
2014
Neck observation is appropriate in T1-2, cN0 oral squamous cell carcinoma without perineural invasion or lymphovascular invasion.
Highly Cited
2011
Highly Cited
2011
Prognostic roles of human equilibrative transporter 1 (hENT‐1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer
Pancreatic adenocarcinoma is a malignancy with a dismal prognosis. Previous studies have suggested that in pancreatic cancer… 
Review
2009
Review
2009
Histologic mimics of perineural invasion
Background: Perineural invasion (PNI) by primary cutaneous cancers is an important adverse risk factor. Certain benign conditions… 
2009
2009
Neural cell adhesion molecule expression: No correlation with perineural invasion in cutaneous squamous cell carcinoma of the head and neck
Perineural invasion (PNI) in cutaneous squamous cell carcinoma of the head and neck (CSCCHN) is associated with decreased… 
2006
2006
Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer.
2003
2003
Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
Review
2003
Review
2003
Allelic losses in localized prostate cancer: association with prognostic factors.
PURPOSE Loss of heterozygosity (LOH) is the most consistent genetic alteration in prostate cancer (CaP), frequently associated… 
2000
2000
Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer.
Review
1999
Review
1999
Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy.
The diagnosis of prostate cancer on needle biopsy is based on a constellation of histologic features. There are, however, three… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)